>
Switch to:

Morphic Holding PB Ratio

: 5.03 (As of Today)
View and export this data going back to 2019. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2021-12-01), Morphic Holding's share price is $47.70. Morphic Holding's Book Value per Share for the quarter that ended in Sep. 2021 was $9.49. Hence, Morphic Holding's PB Ratio of today is 5.03.

Good Sign:

Morphic Holding Inc stock PB Ratio (=4.9) is close to 1-year low of 4.46

The historical rank and industry rank for Morphic Holding's PB Ratio or its related term are showing as below:

NAS:MORF' s PB Ratio Range Over the Past 10 Years
Min: 2.51   Med: 6.03   Max: 8.38
Current: 4.94

2.51
8.38

During the past 4 years, Morphic Holding's highest PB Ratio was 8.38. The lowest was 2.51. And the median was 6.03.

NAS:MORF's PB Ratio is ranked lower than
65% of the 1351 Companies
in the Biotechnology industry.

( Industry Median: 3.44 vs. NAS:MORF: 4.94 )

During the past 12 months, Morphic Holding's average Book Value Per Share Growth Rate was 124.60% per year.

Back to Basics: PB Ratio


Morphic Holding PB Ratio Historical Data

The historical data trend for Morphic Holding's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morphic Holding Annual Data
Trend Dec17 Dec18 Dec19 Dec20
PB Ratio
- - 3.67 7.40

Morphic Holding Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
PB Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.47 7.40 6.20 5.98 5.97

Competitive Comparison

For the Biotechnology subindustry, Morphic Holding's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Morphic Holding PB Ratio Distribution

For the Biotechnology industry and Healthcare sector, Morphic Holding's PB Ratio distribution charts can be found below:

* The bar in red indicates where Morphic Holding's PB Ratio falls into.



Morphic Holding PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Morphic Holding's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2021)
=47.70/9.492
=5.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Morphic Holding  (NAS:MORF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Morphic Holding PB Ratio Related Terms

Thank you for viewing the detailed overview of Morphic Holding's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Morphic Holding Business Description

Morphic Holding logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
35 Gatehouse Drive, A2, Waltham, MA, USA, 02451
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer.
Executives
Farrell Robert E Jr officer: SVP Finance and CAO CAMBRIDGE DISCOVERY PARK 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Lugovskoy Alexey officer: Chief Development Officer C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451
Devaul William officer: General Counsel and Secretary C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451
Slattery Joseph P director C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560
Nashat Amir director 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Stampacchia Otello director 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Springer Timothy A director, 10 percent owner 36 WOODMAN ROAD CHESTNUT HILL MA 02467
Christensen Gustav director DYAX CORP. 300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Bischofberger Norbert W director 333 LAKESIDE DR C/O GILEAD SCIENCES, INC. FOSTER CITY CA 94404
Goyal Vikas director C/O SR ONE, LTD., 161 WASHINGTON ST. SUITE 500, EIGHT TOWER BRIDGE CONSHOHOCKEN PA 19428
Rogers Bruce officer: Chief Scientific Officer C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451
Schegerin Marc officer: CFO and COO ARQULE INC 1 WALL ST FL6 BURLINGTON MA 01803
Linde Peter officer: Chief Medical Officer C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE A2 WALTHAM ME 02451
Tipirneni Praveen P. director, officer: President and CEO C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451
Omega Fund V Gp, L.p. 10 percent owner 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199

Morphic Holding Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)